Targeted Therapy Drugs for Esophageal Cancer

Cancer research · Esophageal cancer · ERBB2

Trastuzumab (Herceptin and other brand names) is a monoclonal antibody, a man-made version of an immune system protein, which targets HER2.

Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.

Original source

Related signals

• Esophageal Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
• Clinical Trials Update in Resectable Esophageal Cancer
• Advances in targeted therapy for esophageal cancer
• A review of esophageal cancer research: emerging trends, progress and perspectives
• An esophageal cancer clinical trial - ES3